EDIT vs HAL
Editas Medicine Inc (EDIT) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
HAL does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the EDIT and HAL stock pages for the full models.
Not investment advice.